<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33810425</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>08</Day></DateCompleted><DateRevised><Year>2021</Year><Month>07</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>7</Issue><PubDate><Year>2021</Year><Month>Mar</Month><Day>26</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Defective Oligodendroglial Lineage and Demyelination in Amyotrophic Lateral Sclerosis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">3426</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms22073426</ELocationID><Abstract><AbstractText>Motor neurons and their axons reaching the skeletal muscle have long been considered as the best characterized targets of the degenerative process observed in amyotrophic lateral sclerosis (ALS). However, the involvement of glial cells was also more recently reported. Although oligodendrocytes have been underestimated for a longer time than other cells, they are presently considered as critically involved in axonal injury and also conversely constitute a target for the toxic effects of the degenerative neurons. In the present review, we highlight the recent advances regarding oligodendroglial cell involvement in the pathogenesis of ALS. First, we present the oligodendroglial cells, the process of myelination, and the tight relationship between axons and myelin. The histological abnormalities observed in ALS and animal models of the disease are described, including myelin defects and oligodendroglial accumulation of pathological protein aggregates. Then, we present data that establish the existence of dysfunctional and degenerating oligodendroglial cells, the chain of events resulting in oligodendrocyte degeneration, and the most recent molecular mechanisms supporting oligodendrocyte death and dysfunction. Finally, we review the arguments in support of the primary versus secondary involvement of oligodendrocytes in the disease and discuss the therapeutic perspectives related to oligodendrocyte implication in ALS pathogenesis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Traiffort</LastName><ForeName>Elisabeth</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Diseases and Hormones of the Nervous System U1195 INSERM, Paris Saclay University, 80 Rue du G&#xe9;n&#xe9;ral Leclerc, 94276 Le Kremlin-Bic&#xea;tre, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morisset-Lopez</LastName><ForeName>S&#xe9;verine</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-9930-7824</Identifier><AffiliationInfo><Affiliation>Centre de Biophysique Mol&#xe9;culaire, UPR 4301 CNRS, Orl&#xe9;ans University, INSERM, rue Charles Sadron, CEDEX 02, 45071 Orleans, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moussaed</LastName><ForeName>Mireille</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centre de Biophysique Mol&#xe9;culaire, UPR 4301 CNRS, Orl&#xe9;ans University, INSERM, rue Charles Sadron, CEDEX 02, 45071 Orleans, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zahaf</LastName><ForeName>Amina</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Diseases and Hormones of the Nervous System U1195 INSERM, Paris Saclay University, 80 Rue du G&#xe9;n&#xe9;ral Leclerc, 94276 Le Kremlin-Bic&#xea;tre, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>RAK19097LLP</GrantID><Agency>Association pour la Recherche sur la Scl&#xe9;rose Lat&#xe9;rale Amyotrophique et autres Maladies du Motoneurone</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>03</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000598624">TARDBP protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="C000606291">Sod1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>S88TT14065</RegistryNumber><NameOfSubstance UI="D010100">Oxygen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001253" MajorTopicYN="N">Astrocytes</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001369" MajorTopicYN="N">Axons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016923" MajorTopicYN="N">Cell Death</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019070" MajorTopicYN="N">Cell Lineage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D049109" MajorTopicYN="N">Cell Proliferation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003711" MajorTopicYN="N">Demyelinating Diseases</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009186" MajorTopicYN="N">Myelin Sheath</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009457" MajorTopicYN="N">Neuroglia</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009836" MajorTopicYN="N">Oligodendroglia</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="Y">cytology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010100" MajorTopicYN="N">Oxygen</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016548" MajorTopicYN="N">Prosencephalon</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">axonal degeneration</Keyword><Keyword MajorTopicYN="N">demyelination</Keyword><Keyword MajorTopicYN="N">oligodendrocyte</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>1</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>3</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>3</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>3</Day><Hour>1</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>4</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33810425</ArticleId><ArticleId IdType="pmc">PMC8036314</ArticleId><ArticleId IdType="doi">10.3390/ijms22073426</ArticleId><ArticleId IdType="pii">ijms22073426</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Morris J. Amyotrophic Lateral Sclerosis (ALS) and Related Motor Neuron Diseases: An Overview. Neurodiagn. J. 2015;55:180&#x2013;194. doi: 10.1080/21646821.2015.1075181.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21646821.2015.1075181</ArticleId><ArticleId IdType="pubmed">26630810</ArticleId></ArticleIdList></Reference><Reference><Citation>Marin B., Boumediene F., Logroscino G., Couratier P., Babron M.C., Leutenegger A.L., Copetti M., Preux P.M., Beghi E. Variation in worldwide incidence of amyotrophic lateral sclerosis: A meta-analysis. Int. J. Epidemiol. 2017;46:57&#x2013;74. doi: 10.1093/ije/dyw061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyw061</ArticleId><ArticleId IdType="pmc">PMC5407171</ArticleId><ArticleId IdType="pubmed">27185810</ArticleId></ArticleIdList></Reference><Reference><Citation>Therrien M., Dion P.A., Rouleau G.A. ALS: Recent Developments from Genetics Studies. Curr. Neurol. Neurosci. Rep. 2016;16:59. doi: 10.1007/s11910-016-0658-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11910-016-0658-1</ArticleId><ArticleId IdType="pubmed">27113253</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou Z.Y., Zhou Z.R., Che C.H., Liu C.Y., He R.L., Huang H.P. Genetic epidemiology of amyotrophic lateral sclerosis: A systematic review and meta-analysis. J. Neurol. Neurosurg. Psychiatry. 2017;88:540&#x2013;549. doi: 10.1136/jnnp-2016-315018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2016-315018</ArticleId><ArticleId IdType="pubmed">28057713</ArticleId></ArticleIdList></Reference><Reference><Citation>Boylan K. Familial Amyotrophic Lateral Sclerosis. Neurol. Clin. 2015;33:807&#x2013;830. doi: 10.1016/j.ncl.2015.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncl.2015.07.001</ArticleId><ArticleId IdType="pmc">PMC4670044</ArticleId><ArticleId IdType="pubmed">26515623</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton A.E., Chio A., Traynor B.J. State of play in amyotrophic lateral sclerosis genetics. Nat. Neurosci. 2014;17:17&#x2013;23. doi: 10.1038/nn.3584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3584</ArticleId><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Pape J.A., Grose J.H. The effects of diet and sex in amyotrophic lateral sclerosis. Rev. Neurol. 2020;176:301&#x2013;315. doi: 10.1016/j.neurol.2019.09.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurol.2019.09.008</ArticleId><ArticleId IdType="pubmed">32147204</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozzoni V., Pansarasa O., Diamanti L., Nosari G., Cereda C., Ceroni M. Amyotrophic lateral sclerosis and environmental factors. Funct. Neurol. 2016;31:7&#x2013;19. doi: 10.11138/FNeur/2016.31.1.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.11138/FNeur/2016.31.1.007</ArticleId><ArticleId IdType="pmc">PMC4819821</ArticleId><ArticleId IdType="pubmed">27027889</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A., Mora G., Moglia C., Manera U., Canosa A., Cammarosano S., Ilardi A., Bertuzzo D., Bersano E., Cugnasco P., et al. Secular Trends of Amyotrophic Lateral Sclerosis: The Piemonte and Valle d&#x2019;Aosta Register. JAMA Neurol. 2017;74:1097&#x2013;1104. doi: 10.1001/jamaneurol.2017.1387.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2017.1387</ArticleId><ArticleId IdType="pmc">PMC5710181</ArticleId><ArticleId IdType="pubmed">28692730</ArticleId></ArticleIdList></Reference><Reference><Citation>Curzio D.D., Gurm M., Turnbull M., Nadeau M.J., Meek B., Rempel J.D., Fineblit S., Jonasson M., Hebert S., Ferguson-Parry J., et al. Pro-Inflammatory Signaling Upregulates a Neurotoxic Conotoxin-Like Protein Encrypted Within Human Endogenous Retrovirus-K. Cells. 2020;9:1584. doi: 10.3390/cells9071584.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9071584</ArticleId><ArticleId IdType="pmc">PMC7407490</ArticleId><ArticleId IdType="pubmed">32629888</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W., Lee M.H., Henderson L., Tyagi R., Bachani M., Steiner J., Campanac E., Hoffman D.A., von Geldern G., Johnson K., et al. Human endogenous retrovirus-K contributes to motor neuron disease. Sci. Transl. Med. 2015;7:307ra153. doi: 10.1126/scitranslmed.aac8201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aac8201</ArticleId><ArticleId IdType="pmc">PMC6344353</ArticleId><ArticleId IdType="pubmed">26424568</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang T., Al Khleifat A., Meurgey J.H., Jones A., Leigh P.N., Bensimon G., Al-Chalabi A. Stage at which riluzole treatment prolongs survival in patients with amyotrophic lateral sclerosis: A retrospective analysis of data from a dose-ranging study. Lancet Neurol. 2018;17:416&#x2013;422. doi: 10.1016/S1474-4422(18)30054-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(18)30054-1</ArticleId><ArticleId IdType="pmc">PMC5899963</ArticleId><ArticleId IdType="pubmed">29525492</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathis S., Couratier P., Julian A., Vallat J.M., Corcia P., Le Masson G. Management and therapeutic perspectives in amyotrophic lateral sclerosis. Expert Rev. Neurother. 2017;17:263&#x2013;276. doi: 10.1080/14737175.2016.1227705.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14737175.2016.1227705</ArticleId><ArticleId IdType="pubmed">27644548</ArticleId></ArticleIdList></Reference><Reference><Citation>Vucic S., Lin C.S., Cheah B.C., Murray J., Menon P., Krishnan A.V., Kiernan M.C. Riluzole exerts central and peripheral modulating effects in amyotrophic lateral sclerosis. Brain. 2013;136:1361&#x2013;1370. doi: 10.1093/brain/awt085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awt085</ArticleId><ArticleId IdType="pubmed">23616585</ArticleId></ArticleIdList></Reference><Reference><Citation>Bissaro M., Moro S. Rethinking to riluzole mechanism of action: The molecular link among protein kinase CK1delta activity, TDP-43 phosphorylation, and amyotrophic lateral sclerosis pharmacological treatment. Neural Regen Res. 2019;14:2083&#x2013;2085. doi: 10.4103/1673-5374.262578.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.262578</ArticleId><ArticleId IdType="pmc">PMC6788255</ArticleId><ArticleId IdType="pubmed">31397342</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshino H., Kimura A. Investigation of the therapeutic effects of edaravone, a free radical scavenger, on amyotrophic lateral sclerosis (Phase II study) Amyotroph. Lateral Scler. 2006;7:241&#x2013;245. doi: 10.1080/17482960600881870.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960600881870</ArticleId><ArticleId IdType="pubmed">17127563</ArticleId></ArticleIdList></Reference><Reference><Citation>Wootz H., Fitzsimons-Kantamneni E., Larhammar M., Rotterman T.M., Enjin A., Patra K., Andre E., Van Zundert B., Kullander K., Alvarez F.J. Alterations in the motor neuron-renshaw cell circuit in the Sod1(G93A) mouse model. J. Comp. Neurol. 2013;521:1449&#x2013;1469. doi: 10.1002/cne.23266.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.23266</ArticleId><ArticleId IdType="pmc">PMC3604165</ArticleId><ArticleId IdType="pubmed">23172249</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng A.S., Rademakers R., Miller B.L. Frontotemporal dementia: A bridge between dementia and neuromuscular disease. Ann. N. Y. Acad. Sci. 2015;1338:71&#x2013;93. doi: 10.1111/nyas.12638.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nyas.12638</ArticleId><ArticleId IdType="pmc">PMC4399703</ArticleId><ArticleId IdType="pubmed">25557955</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J., Hughes E.G., Shetty A.S., Arlotta P., Goff L.A., Bergles D.E., Brown S.P. Changes in the Excitability of Neocortical Neurons in a Mouse Model of Amyotrophic Lateral Sclerosis Are Not Specific to Corticospinal Neurons and Are Modulated by Advancing Disease. J. Neurosci. 2017;37:9037&#x2013;9053. doi: 10.1523/JNEUROSCI.0811-17.2017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0811-17.2017</ArticleId><ArticleId IdType="pmc">PMC5597984</ArticleId><ArticleId IdType="pubmed">28821643</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaughan S.K., Sutherland N.M., Zhang S., Hatzipetros T., Vieira F., Valdez G. The ALS-inducing factors, TDP43(A315T) and SOD1(G93A), directly affect and sensitize sensory neurons to stress. Sci. Rep. 2018;8:16582. doi: 10.1038/s41598-018-34510-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-34510-8</ArticleId><ArticleId IdType="pmc">PMC6224462</ArticleId><ArticleId IdType="pubmed">30410094</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O&#x2019;Regan J.P., Deng H.X., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59&#x2013;62. doi: 10.1038/362059a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Clement A.M., Nguyen M.D., Roberts E.A., Garcia M.L., Boillee S., Rule M., McMahon A.P., Doucette W., Siwek D., Ferrante R.J., et al. Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science. 2003;302:113&#x2013;117. doi: 10.1126/science.1086071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1086071</ArticleId><ArticleId IdType="pubmed">14526083</ArticleId></ArticleIdList></Reference><Reference><Citation>Boillee S., Yamanaka K., Lobsiger C.S., Copeland N.G., Jenkins N.A., Kassiotis G., Kollias G., Cleveland D.W. Onset and progression in inherited ALS determined by motor neurons and microglia. Science. 2006;312:1389&#x2013;1392. doi: 10.1126/science.1123511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1123511</ArticleId><ArticleId IdType="pubmed">16741123</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka K., Chun S.J., Boillee S., Fujimori-Tonou N., Yamashita H., Gutmann D.H., Takahashi R., Misawa H., Cleveland D.W. Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat. Neurosci. 2008;11:251&#x2013;253. doi: 10.1038/nn2047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn2047</ArticleId><ArticleId IdType="pmc">PMC3137510</ArticleId><ArticleId IdType="pubmed">18246065</ArticleId></ArticleIdList></Reference><Reference><Citation>Rafalowska J., Dziewulska D. White matter injury in amyotrophic lateral sclerosis (ALS) Folia Neuropathol. 1996;34:87&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">8791897</ArticleId></ArticleIdList></Reference><Reference><Citation>Sach M., Winkler G., Glauche V., Liepert J., Heimbach B., Koch M.A., Buchel C., Weiller C. Diffusion tensor MRI of early upper motor neuron involvement in amyotrophic lateral sclerosis. Brain. 2004;127:340&#x2013;350. doi: 10.1093/brain/awh041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awh041</ArticleId><ArticleId IdType="pubmed">14607785</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie I.R., Ansorge O., Strong M., Bilbao J., Zinman L., Ang L.C., Baker M., Stewart H., Eisen A., Rademakers R., et al. Pathological heterogeneity in amyotrophic lateral sclerosis with FUS mutations: Two distinct patterns correlating with disease severity and mutation. Acta Neuropathol. 2011;122:87&#x2013;98. doi: 10.1007/s00401-011-0838-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-011-0838-7</ArticleId><ArticleId IdType="pmc">PMC3319073</ArticleId><ArticleId IdType="pubmed">21604077</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Kwong L.K., Truax A.C., Vanmassenhove B., Kretzschmar H.A., Van Deerlin V.M., Clark C.M., Grossman M., Miller B.L., Trojanowski J.Q., et al. TDP-43-positive white matter pathology in frontotemporal lobar degeneration with ubiquitin-positive inclusions. J. Neuropathol. Exp. Neurol. 2007;66:177&#x2013;183. doi: 10.1097/01.jnen.0000248554.45456.58.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.jnen.0000248554.45456.58</ArticleId><ArticleId IdType="pubmed">17356379</ArticleId></ArticleIdList></Reference><Reference><Citation>Niebroj-Dobosz I., Rafalowska J., Fidzianska A., Gadamski R., Grieb P. Myelin composition of spinal cord in a model of amyotrophic lateral sclerosis (ALS) in SOD1G93A transgenic rats. Folia Neuropathol. 2007;45:236&#x2013;241.</Citation><ArticleIdList><ArticleId IdType="pubmed">18176898</ArticleId></ArticleIdList></Reference><Reference><Citation>Seilhean D., Cazeneuve C., Thuries V., Russaouen O., Millecamps S., Salachas F., Meininger V., Leguern E., Duyckaerts C. Accumulation of TDP-43 and alpha-actin in an amyotrophic lateral sclerosis patient with the K17I ANG mutation. Acta Neuropathol. 2009;118:561&#x2013;573. doi: 10.1007/s00401-009-0545-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-009-0545-9</ArticleId><ArticleId IdType="pubmed">19449021</ArticleId></ArticleIdList></Reference><Reference><Citation>Kessaris N., Fogarty M., Iannarelli P., Grist M., Wegner M., Richardson W.D. Competing waves of oligodendrocytes in the forebrain and postnatal elimination of an embryonic lineage. Nat. Neurosci. 2006;9:173&#x2013;179. doi: 10.1038/nn1620.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1620</ArticleId><ArticleId IdType="pmc">PMC6328015</ArticleId><ArticleId IdType="pubmed">16388308</ArticleId></ArticleIdList></Reference><Reference><Citation>Traiffort E., Zakaria M., Laouarem Y., Ferent J. Hedgehog: A key signaling in the development of the oligodendrocyte lineage. J. Dev. Biol. 2016;4:28. doi: 10.3390/jdb4030028.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jdb4030028</ArticleId><ArticleId IdType="pmc">PMC5831774</ArticleId><ArticleId IdType="pubmed">29615592</ArticleId></ArticleIdList></Reference><Reference><Citation>Back S.A., Luo N.L., Borenstein N.S., Levine J.M., Volpe J.J., Kinney H.C. Late oligodendrocyte progenitors coincide with the developmental window of vulnerability for human perinatal white matter injury. J. Neurosci. 2001;21:1302&#x2013;1312. doi: 10.1523/JNEUROSCI.21-04-01302.2001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.21-04-01302.2001</ArticleId><ArticleId IdType="pmc">PMC6762224</ArticleId><ArticleId IdType="pubmed">11160401</ArticleId></ArticleIdList></Reference><Reference><Citation>Jakovcevski I., Filipovic R., Mo Z., Rakic S., Zecevic N. Oligodendrocyte development and the onset of myelination in the human fetal brain. Front. Neuroanat. 2009;3:5. doi: 10.3389/neuro.05.005.2009.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/neuro.05.005.2009</ArticleId><ArticleId IdType="pmc">PMC2694674</ArticleId><ArticleId IdType="pubmed">19521542</ArticleId></ArticleIdList></Reference><Reference><Citation>Sim F.J., McClain C.R., Schanz S.J., Protack T.L., Windrem M.S., Goldman S.A. CD140a identifies a population of highly myelinogenic, migration-competent and efficiently engrafting human oligodendrocyte progenitor cells. Nat. Biotechnol. 2011;29:934&#x2013;941. doi: 10.1038/nbt.1972.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.1972</ArticleId><ArticleId IdType="pmc">PMC3365580</ArticleId><ArticleId IdType="pubmed">21947029</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrer I. Oligodendrogliopathy in neurodegenerative diseases with abnormal protein aggregates: The forgotten partner. Prog. Neurobiol. 2018;169:24&#x2013;54. doi: 10.1016/j.pneurobio.2018.07.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2018.07.004</ArticleId><ArticleId IdType="pubmed">30077775</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H., Richardson W.D. Evolution of the CNS myelin gene regulatory program. Brain Res. 2016;1641:111&#x2013;121. doi: 10.1016/j.brainres.2015.10.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2015.10.013</ArticleId><ArticleId IdType="pmc">PMC6326354</ArticleId><ArticleId IdType="pubmed">26474911</ArticleId></ArticleIdList></Reference><Reference><Citation>Marinelli C., Bertalot T., Zusso M., Skaper S.D., Giusti P. Systematic Review of Pharmacological Properties of the Oligodendrocyte Lineage. Front. Cell. Neurosci. 2016;10:27. doi: 10.3389/fncel.2016.00027.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2016.00027</ArticleId><ArticleId IdType="pmc">PMC4751280</ArticleId><ArticleId IdType="pubmed">26903812</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergles D.E., Richardson W.D. Oligodendrocyte Development and Plasticity. Cold Spring Harb. Perspect. Biol. 2015;8:a020453. doi: 10.1101/cshperspect.a020453.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a020453</ArticleId><ArticleId IdType="pmc">PMC4743079</ArticleId><ArticleId IdType="pubmed">26492571</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller R.H. Regulation of oligodendrocyte development in the vertebrate CNS. Prog. Neurobiol. 2002;67:451&#x2013;467. doi: 10.1016/S0301-0082(02)00058-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0301-0082(02)00058-8</ArticleId><ArticleId IdType="pubmed">12385864</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishiyama A., Boshans L., Goncalves C.M., Wegrzyn J., Patel K.D. Lineage, fate, and fate potential of NG2-glia. Brain Res. 2016;1638:116&#x2013;128. doi: 10.1016/j.brainres.2015.08.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2015.08.013</ArticleId><ArticleId IdType="pmc">PMC4761528</ArticleId><ArticleId IdType="pubmed">26301825</ArticleId></ArticleIdList></Reference><Reference><Citation>Crawford A.H., Tripathi R.B., Richardson W.D., Franklin R.J. Developmental Origin of Oligodendrocyte Lineage Cells Determines Response to Demyelination and Susceptibility to Age-Associated Functional Decline. Cell Rep. 2016 doi: 10.1016/j.celrep.2016.03.069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2016.03.069</ArticleId><ArticleId IdType="pmc">PMC4850420</ArticleId><ArticleId IdType="pubmed">27149850</ArticleId></ArticleIdList></Reference><Reference><Citation>Vigano F., Schneider S., Cimino M., Bonfanti E., Gelosa P., Sironi L., Abbracchio M.P., Dimou L. GPR17 expressing NG2-Glia: Oligodendrocyte progenitors serving as a reserve pool after injury. Glia. 2016;64:287&#x2013;299. doi: 10.1002/glia.22929.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.22929</ArticleId><ArticleId IdType="pubmed">26464068</ArticleId></ArticleIdList></Reference><Reference><Citation>Marques S., Zeisel A., Codeluppi S., van Bruggen D., Mendanha Falcao A., Xiao L., Li H., Haring M., Hochgerner H., Romanov R.A., et al. Oligodendrocyte heterogeneity in the mouse juvenile and adult central nervous system. Science. 2016;352:1326&#x2013;1329. doi: 10.1126/science.aaf6463.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf6463</ArticleId><ArticleId IdType="pmc">PMC5221728</ArticleId><ArticleId IdType="pubmed">27284195</ArticleId></ArticleIdList></Reference><Reference><Citation>Floriddia E.M., Lourenco T., Zhang S., van Bruggen D., Hilscher M.M., Kukanja P., Goncalves Dos Santos J.P., Altinkok M., Yokota C., Llorens-Bobadilla E., et al. Distinct oligodendrocyte populations have spatial preference and different responses to spinal cord injury. Nat. Commun. 2020;11:5860. doi: 10.1038/s41467-020-19453-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-19453-x</ArticleId><ArticleId IdType="pmc">PMC7673029</ArticleId><ArticleId IdType="pubmed">33203872</ArticleId></ArticleIdList></Reference><Reference><Citation>Sim F.J., Lang J.K., Waldau B., Roy N.S., Schwartz T.E., Pilcher W.H., Chandross K.J., Natesan S., Merrill J.E., Goldman S.A. Complementary patterns of gene expression by human oligodendrocyte progenitors and their environment predict determinants of progenitor maintenance and differentiation. Ann. Neurol. 2006;59:763&#x2013;779. doi: 10.1002/ana.20812.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.20812</ArticleId><ArticleId IdType="pubmed">16634042</ArticleId></ArticleIdList></Reference><Reference><Citation>Stadelmann C., Timmler S., Barrantes-Freer A., Simons M. Myelin in the Central Nervous System: Structure, Function, and Pathology. Physiol. Rev. 2019;99:1381&#x2013;1431. doi: 10.1152/physrev.00031.2018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00031.2018</ArticleId><ArticleId IdType="pubmed">31066630</ArticleId></ArticleIdList></Reference><Reference><Citation>Aggarwal S., Snaidero N., Pahler G., Frey S., Sanchez P., Zweckstetter M., Janshoff A., Schneider A., Weil M.T., Schaap I.A., et al. Myelin membrane assembly is driven by a phase transition of myelin basic proteins into a cohesive protein meshwork. PLoS Biol. 2013;11:e1001577. doi: 10.1371/journal.pbio.1001577.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.1001577</ArticleId><ArticleId IdType="pmc">PMC3676292</ArticleId><ArticleId IdType="pubmed">23762018</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller C., Bauer N.M., Schafer I., White R. Making myelin basic protein -from mRNA transport to localized translation. Front. Cell. Neurosci. 2013;7:169. doi: 10.3389/fncel.2013.00169.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2013.00169</ArticleId><ArticleId IdType="pmc">PMC3784684</ArticleId><ArticleId IdType="pubmed">24098271</ArticleId></ArticleIdList></Reference><Reference><Citation>Snaidero N., Mobius W., Czopka T., Hekking L.H., Mathisen C., Verkleij D., Goebbels S., Edgar J., Merkler D., Lyons D.A., et al. Myelin membrane wrapping of CNS axons by PI(3,4,5)P3-dependent polarized growth at the inner tongue. Cell. 2014;156:277&#x2013;290. doi: 10.1016/j.cell.2013.11.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2013.11.044</ArticleId><ArticleId IdType="pmc">PMC4862569</ArticleId><ArticleId IdType="pubmed">24439382</ArticleId></ArticleIdList></Reference><Reference><Citation>Snaidero N., Velte C., Myllykoski M., Raasakka A., Ignatev A., Werner H.B., Erwig M.S., Mobius W., Kursula P., Nave K.A., et al. Antagonistic Functions of MBP and CNP Establish Cytosolic Channels in CNS Myelin. Cell Rep. 2017;18:314&#x2013;323. doi: 10.1016/j.celrep.2016.12.053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2016.12.053</ArticleId><ArticleId IdType="pmc">PMC5263235</ArticleId><ArticleId IdType="pubmed">28076777</ArticleId></ArticleIdList></Reference><Reference><Citation>Nave K.A., Werner H.B. Myelination of the nervous system: Mechanisms and functions. Annu. Rev. Cell Dev. Biol. 2014;30:503&#x2013;533. doi: 10.1146/annurev-cellbio-100913-013101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-cellbio-100913-013101</ArticleId><ArticleId IdType="pubmed">25288117</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomassy G.S., Berger D.R., Chen H.H., Kasthuri N., Hayworth K.J., Vercelli A., Seung H.S., Lichtman J.W., Arlotta P. Distinct profiles of myelin distribution along single axons of pyramidal neurons in the neocortex. Science. 2014;344:319&#x2013;324. doi: 10.1126/science.1249766.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1249766</ArticleId><ArticleId IdType="pmc">PMC4122120</ArticleId><ArticleId IdType="pubmed">24744380</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishibashi T., Dakin K.A., Stevens B., Lee P.R., Kozlov S.V., Stewart C.L., Fields R.D. Astrocytes promote myelination in response to electrical impulses. Neuron. 2006;49:823&#x2013;832. doi: 10.1016/j.neuron.2006.02.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2006.02.006</ArticleId><ArticleId IdType="pmc">PMC1474838</ArticleId><ArticleId IdType="pubmed">16543131</ArticleId></ArticleIdList></Reference><Reference><Citation>Camargo N., Goudriaan A., van Deijk A.F., Otte W.M., Brouwers J.F., Lodder H., Gutmann D.H., Nave K.A., Dijkhuizen R.M., Mansvelder H.D., et al. Oligodendroglial myelination requires astrocyte-derived lipids. PLoS Biol. 2017;15:e1002605. doi: 10.1371/journal.pbio.1002605.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.1002605</ArticleId><ArticleId IdType="pmc">PMC5446120</ArticleId><ArticleId IdType="pubmed">28549068</ArticleId></ArticleIdList></Reference><Reference><Citation>Dutta D.J., Woo D.H., Lee P.R., Pajevic S., Bukalo O., Huffman W.C., Wake H., Basser P.J., SheikhBahaei S., Lazarevic V., et al. Regulation of myelin structure and conduction velocity by perinodal astrocytes. Proc. Natl. Acad. Sci. USA. 2018;115:11832&#x2013;11837. doi: 10.1073/pnas.1811013115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1811013115</ArticleId><ArticleId IdType="pmc">PMC6243273</ArticleId><ArticleId IdType="pubmed">30373833</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagemeyer N., Hanft K.M., Akriditou M.A., Unger N., Park E.S., Stanley E.R., Staszewski O., Dimou L., Prinz M. Microglia contribute to normal myelinogenesis and to oligodendrocyte progenitor maintenance during adulthood. Acta Neuropathol. 2017;134:441&#x2013;458. doi: 10.1007/s00401-017-1747-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1747-1</ArticleId><ArticleId IdType="pmc">PMC5951721</ArticleId><ArticleId IdType="pubmed">28685323</ArticleId></ArticleIdList></Reference><Reference><Citation>Wlodarczyk A., Holtman I.R., Krueger M., Yogev N., Bruttger J., Khorooshi R., Benmamar-Badel A., de Boer-Bergsma J.J., Martin N.A., Karram K., et al. A novel microglial subset plays a key role in myelinogenesis in developing brain. EMBO J. 2017;36:3292&#x2013;3308. doi: 10.15252/embj.201696056.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201696056</ArticleId><ArticleId IdType="pmc">PMC5686552</ArticleId><ArticleId IdType="pubmed">28963396</ArticleId></ArticleIdList></Reference><Reference><Citation>Giera S., Deng Y., Luo R., Ackerman S.D., Mogha A., Monk K.R., Ying Y., Jeong S.J., Makinodan M., Bialas A.R., et al. The adhesion G protein-coupled receptor GPR56 is a cell-autonomous regulator of oligodendrocyte development. Nat. Commun. 2015;6:6121. doi: 10.1038/ncomms7121.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms7121</ArticleId><ArticleId IdType="pmc">PMC4302951</ArticleId><ArticleId IdType="pubmed">25607655</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho A.N., Jin Y., Kim S., Kumar S., Shin H., Kang H.C., Cho S.W. Aligned Brain Extracellular Matrix Promotes Differentiation and Myelination of Human-Induced Pluripotent Stem Cell-Derived Oligodendrocytes. ACS Appl. Mater. Interfaces. 2019;11:15344&#x2013;15353. doi: 10.1021/acsami.9b03242.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsami.9b03242</ArticleId><ArticleId IdType="pubmed">30974942</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffiths I., Klugmann M., Anderson T., Yool D., Thomson C., Schwab M.H., Schneider A., Zimmermann F., McCulloch M., Nadon N., et al. Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science. 1998;280:1610&#x2013;1613. doi: 10.1126/science.280.5369.1610.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.280.5369.1610</ArticleId><ArticleId IdType="pubmed">9616125</ArticleId></ArticleIdList></Reference><Reference><Citation>Kassmann C.M., Lappe-Siefke C., Baes M., Brugger B., Mildner A., Werner H.B., Natt O., Michaelis T., Prinz M., Frahm J., et al. Axonal loss and neuroinflammation caused by peroxisome-deficient oligodendrocytes. Nat. Genet. 2007;39:969&#x2013;976. doi: 10.1038/ng2070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng2070</ArticleId><ArticleId IdType="pubmed">17643102</ArticleId></ArticleIdList></Reference><Reference><Citation>Lappe-Siefke C., Goebbels S., Gravel M., Nicksch E., Lee J., Braun P.E., Griffiths I.R., Nave K.A. Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination. Nat. Genet. 2003;33:366&#x2013;374. doi: 10.1038/ng1095.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1095</ArticleId><ArticleId IdType="pubmed">12590258</ArticleId></ArticleIdList></Reference><Reference><Citation>Boullerne A.I. The history of myelin. Exp. Neurol. 2016;283:431&#x2013;445. doi: 10.1016/j.expneurol.2016.06.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2016.06.005</ArticleId><ArticleId IdType="pmc">PMC5010938</ArticleId><ArticleId IdType="pubmed">27288241</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartline D.K., Colman D.R. Rapid conduction and the evolution of giant axons and myelinated fibers. Curr. Biol. 2007;17:R29&#x2013;R35. doi: 10.1016/j.cub.2006.11.042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2006.11.042</ArticleId><ArticleId IdType="pubmed">17208176</ArticleId></ArticleIdList></Reference><Reference><Citation>Funfschilling U., Supplie L.M., Mahad D., Boretius S., Saab A.S., Edgar J., Brinkmann B.G., Kassmann C.M., Tzvetanova I.D., Mobius W., et al. Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity. Nature. 2012;485:517&#x2013;521. doi: 10.1038/nature11007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11007</ArticleId><ArticleId IdType="pmc">PMC3613737</ArticleId><ArticleId IdType="pubmed">22622581</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y., Morrison B.M., Li Y., Lengacher S., Farah M.H., Hoffman P.N., Liu Y., Tsingalia A., Jin L., Zhang P.W., et al. Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature. 2012;487:443&#x2013;448. doi: 10.1038/nature11314.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11314</ArticleId><ArticleId IdType="pmc">PMC3408792</ArticleId><ArticleId IdType="pubmed">22801498</ArticleId></ArticleIdList></Reference><Reference><Citation>Saab A.S., Tzvetavona I.D., Trevisiol A., Baltan S., Dibaj P., Kusch K., Mobius W., Goetze B., Jahn H.M., Huang W., et al. Oligodendroglial NMDA Receptors Regulate Glucose Import and Axonal Energy Metabolism. Neuron. 2016;91:119&#x2013;132. doi: 10.1016/j.neuron.2016.05.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.05.016</ArticleId><ArticleId IdType="pubmed">27292539</ArticleId></ArticleIdList></Reference><Reference><Citation>Hildebrand C., Remahl S., Persson H., Bjartmar C. Myelinated nerve fibres in the CNS. Prog. Neurobiol. 1993;40:319&#x2013;384. doi: 10.1016/0301-0082(93)90015-K.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0301-0082(93)90015-K</ArticleId><ArticleId IdType="pubmed">8441812</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes E.G., Orthmann-Murphy J.L., Langseth A.J., Bergles D.E. Myelin remodeling through experience-dependent oligodendrogenesis in the adult somatosensory cortex. Nat. Neurosci. 2018;21:696&#x2013;706. doi: 10.1038/s41593-018-0121-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0121-5</ArticleId><ArticleId IdType="pmc">PMC5920726</ArticleId><ArticleId IdType="pubmed">29556025</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeung M.S., Zdunek S., Bergmann O., Bernard S., Salehpour M., Alkass K., Perl S., Tisdale J., Possnert G., Brundin L., et al. Dynamics of oligodendrocyte generation and myelination in the human brain. Cell. 2014;159:766&#x2013;774. doi: 10.1016/j.cell.2014.10.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2014.10.011</ArticleId><ArticleId IdType="pubmed">25417154</ArticleId></ArticleIdList></Reference><Reference><Citation>McLaurin J.A., Yong V.W. Oligodendrocytes and myelin. Neurol. Clin. 1995;13:23&#x2013;49. doi: 10.1016/S0733-8619(18)30060-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0733-8619(18)30060-4</ArticleId><ArticleId IdType="pubmed">7739504</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludwin S.K. The pathobiology of the oligodendrocyte. J. Neuropathol. Exp. Neurol. 1997;56:111&#x2013;124. doi: 10.1097/00005072-199702000-00001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005072-199702000-00001</ArticleId><ArticleId IdType="pubmed">9034364</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirrlinger J., Nave K.A. Adapting brain metabolism to myelination and long-range signal transduction. Glia. 2014;62:1749&#x2013;1761. doi: 10.1002/glia.22737.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.22737</ArticleId><ArticleId IdType="pubmed">25130164</ArticleId></ArticleIdList></Reference><Reference><Citation>Toyama B.H., Savas J.N., Park S.K., Harris M.S., Ingolia N.T., Yates J.R., 3rd, Hetzer M.W. Identification of long-lived proteins reveals exceptional stability of essential cellular structures. Cell. 2013;154:971&#x2013;982. doi: 10.1016/j.cell.2013.07.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2013.07.037</ArticleId><ArticleId IdType="pmc">PMC3788602</ArticleId><ArticleId IdType="pubmed">23993091</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka K., Komine O. The multi-dimensional roles of astrocytes in ALS. Neurosci. Res. 2018;126:31&#x2013;38. doi: 10.1016/j.neures.2017.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neures.2017.09.011</ArticleId><ArticleId IdType="pubmed">29054467</ArticleId></ArticleIdList></Reference><Reference><Citation>Geloso M.C., Corvino V., Marchese E., Serrano A., Michetti F., D&#x2019;Ambrosi N. The Dual Role of Microglia in ALS: Mechanisms and Therapeutic Approaches. Front. Aging Neurosci. 2017;9:242. doi: 10.3389/fnagi.2017.00242.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2017.00242</ArticleId><ArticleId IdType="pmc">PMC5524666</ArticleId><ArticleId IdType="pubmed">28790913</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M., et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130&#x2013;133. doi: 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabashi E., Valdmanis P.N., Dion P., Spiegelman D., McConkey B.J., Vande Velde C., Bouchard J.P., Lacomblez L., Pochigaeva K., Salachas F., et al. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat. Genet. 2008;40:572&#x2013;574. doi: 10.1038/ng.132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.132</ArticleId><ArticleId IdType="pubmed">18372902</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray M.E., DeJesus-Hernandez M., Rutherford N.J., Baker M., Duara R., Graff-Radford N.R., Wszolek Z.K., Ferman T.J., Josephs K.A., Boylan K.B., et al. Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72. Acta Neuropathol. 2011;122:673&#x2013;690. doi: 10.1007/s00401-011-0907-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-011-0907-y</ArticleId><ArticleId IdType="pmc">PMC3277860</ArticleId><ArticleId IdType="pubmed">22083254</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie I.R., Bigio E.H., Ince P.G., Geser F., Neumann M., Cairns N.J., Kwong L.K., Forman M.S., Ravits J., Stewart H., et al. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann. Neurol. 2007;61:427&#x2013;434. doi: 10.1002/ana.21147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21147</ArticleId><ArticleId IdType="pubmed">17469116</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J., Arai K., Del Tredici K., Toledo J.B., Robinson J.L., Lee E.B., Kuwabara S., Shibuya K., Irwin D.J., Fang L., et al. TDP-43 pathology and neuronal loss in amyotrophic lateral sclerosis spinal cord. Acta Neuropathol. 2014;128:423&#x2013;437. doi: 10.1007/s00401-014-1299-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-014-1299-6</ArticleId><ArticleId IdType="pmc">PMC4384652</ArticleId><ArticleId IdType="pubmed">24916269</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolind S., Sharma R., Knight S., Johansen-Berg H., Talbot K., Turner M.R. Myelin imaging in amyotrophic and primary lateral sclerosis. Amyotroph. Lateral Scler. Front. Degener. 2013;14:562&#x2013;573. doi: 10.3109/21678421.2013.794843.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.794843</ArticleId><ArticleId IdType="pmc">PMC3837681</ArticleId><ArticleId IdType="pubmed">23678852</ArticleId></ArticleIdList></Reference><Reference><Citation>Guipponi M., Li Q.X., Hyde L., Beissbarth T., Smyth G.K., Masters C.L., Scott H.S. SAGE analysis of genes differentially expressed in presymptomatic TgSOD1G93A transgenic mice identified cellular processes involved in early stage of ALS pathology. J. Mol. Neurosci. 2010;41:172&#x2013;182. doi: 10.1007/s12031-009-9317-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-009-9317-1</ArticleId><ArticleId IdType="pubmed">19953340</ArticleId></ArticleIdList></Reference><Reference><Citation>Silverman J.M., Christy D., Shyu C.C., Moon K.M., Fernando S., Gidden Z., Cowan C.M., Ban Y., Stacey R.G., Grad L.I., et al. CNS-derived extracellular vesicles from superoxide dismutase 1 (SOD1)(G93A) ALS mice originate from astrocytes and neurons and carry misfolded SOD1. J. Biol. Chem. 2019;294:3744&#x2013;3759. doi: 10.1074/jbc.RA118.004825.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA118.004825</ArticleId><ArticleId IdType="pmc">PMC6416428</ArticleId><ArticleId IdType="pubmed">30635404</ArticleId></ArticleIdList></Reference><Reference><Citation>Golubczyk D., Malysz-Cymborska I., Kalkowski L., Janowski M., Coates J.R., Wojtkiewicz J., Maksymowicz W., Walczak P. The Role of Glia in Canine Degenerative Myelopathy: Relevance to Human Amyotrophic Lateral Sclerosis. Mol. Neurobiol. 2019;56:5740&#x2013;5748. doi: 10.1007/s12035-019-1488-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-019-1488-3</ArticleId><ArticleId IdType="pmc">PMC6614142</ArticleId><ArticleId IdType="pubmed">30674036</ArticleId></ArticleIdList></Reference><Reference><Citation>Ditsworth D., Maldonado M., McAlonis-Downes M., Sun S., Seelman A., Drenner K., Arnold E., Ling S.C., Pizzo D., Ravits J., et al. Mutant TDP-43 within motor neurons drives disease onset but not progression in amyotrophic lateral sclerosis. Acta Neuropathol. 2017;133:907&#x2013;922. doi: 10.1007/s00401-017-1698-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1698-6</ArticleId><ArticleId IdType="pmc">PMC5427168</ArticleId><ArticleId IdType="pubmed">28357566</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier-Tourenne C., Polymenidou M., Hutt K.R., Vu A.Q., Baughn M., Huelga S.C., Clutario K.M., Ling S.C., Liang T.Y., Mazur C., et al. Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs. Nat. Neurosci. 2012;15:1488&#x2013;1497. doi: 10.1038/nn.3230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3230</ArticleId><ArticleId IdType="pmc">PMC3586380</ArticleId><ArticleId IdType="pubmed">23023293</ArticleId></ArticleIdList></Reference><Reference><Citation>Philips T., Bento-Abreu A., Nonneman A., Haeck W., Staats K., Geelen V., Hersmus N., Kusters B., Van Den Bosch L., Van Damme P., et al. Oligodendrocyte dysfunction in the pathogenesis of amyotrophic lateral sclerosis. Brain. 2013;136:471&#x2013;482. doi: 10.1093/brain/aws339.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aws339</ArticleId><ArticleId IdType="pmc">PMC3572934</ArticleId><ArticleId IdType="pubmed">23378219</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan C.F., Eguchi H., Tagawa A., Onodera O., Iwasaki T., Tsujino A., Nishizawa M., Kakita A., Takahashi H. TDP-43 immunoreactivity in neuronal inclusions in familial amyotrophic lateral sclerosis with or without SOD1 gene mutation. Acta Neuropathol. 2007;113:535&#x2013;542. doi: 10.1007/s00401-007-0206-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-007-0206-9</ArticleId><ArticleId IdType="pubmed">17333220</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y., Tang C., Zhu L., Li J., Liang H., Zhang J., Xu R. The Overexpression of TDP-43 Protein in the Neuron and Oligodendrocyte Cells Causes the Progressive Motor Neuron Degeneration in the SOD1 G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis. Int. J. Biol. Sci. 2016;12:1140&#x2013;1149. doi: 10.7150/ijbs.15938.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.15938</ArticleId><ArticleId IdType="pmc">PMC4997058</ArticleId><ArticleId IdType="pubmed">27570488</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper-Knock J., Kirby J., Highley R., Shaw P.J. The Spectrum of C9orf72-mediated Neurodegeneration and Amyotrophic Lateral Sclerosis. Neurotherapeutics. 2015;12:326&#x2013;339. doi: 10.1007/s13311-015-0342-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-015-0342-1</ArticleId><ArticleId IdType="pmc">PMC4404438</ArticleId><ArticleId IdType="pubmed">25731823</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito Y., Ofengeim D., Najafov A., Das S., Saberi S., Li Y., Hitomi J., Zhu H., Chen H., Mayo L., et al. RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS. Science. 2016;353:603&#x2013;608. doi: 10.1126/science.aaf6803.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf6803</ArticleId><ArticleId IdType="pmc">PMC5444917</ArticleId><ArticleId IdType="pubmed">27493188</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishii T., Kawakami E., Endo K., Misawa H., Watabe K. Formation and spreading of TDP-43 aggregates in cultured neuronal and glial cells demonstrated by time-lapse imaging. PLoS ONE. 2017;12:e0179375. doi: 10.1371/journal.pone.0179375.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0179375</ArticleId><ArticleId IdType="pmc">PMC5466347</ArticleId><ArticleId IdType="pubmed">28599005</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Ho W.Y., Lim K., Feng J., Tucker-Kellogg G., Nave K.A., Ling S.C. Cell-autonomous requirement of TDP-43, an ALS/FTD signature protein, for oligodendrocyte survival and myelination. Proc. Natl. Acad. Sci. USA. 2018;115:E10941&#x2013;E10950. doi: 10.1073/pnas.1809821115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1809821115</ArticleId><ArticleId IdType="pmc">PMC6243235</ArticleId><ArticleId IdType="pubmed">30373824</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie I.R., Munoz D.G., Kusaka H., Yokota O., Ishihara K., Roeber S., Kretzschmar H.A., Cairns N.J., Neumann M. Distinct pathological subtypes of FTLD-FUS. Acta Neuropathol. 2011;121:207&#x2013;218. doi: 10.1007/s00401-010-0764-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-010-0764-0</ArticleId><ArticleId IdType="pubmed">21052700</ArticleId></ArticleIdList></Reference><Reference><Citation>Scekic-Zahirovic J., Oussini H.E., Mersmann S., Drenner K., Wagner M., Sun Y., Allmeroth K., Dieterle S., Sinniger J., Dirrig-Grosch S., et al. Motor neuron intrinsic and extrinsic mechanisms contribute to the pathogenesis of FUS-associated amyotrophic lateral sclerosis. Acta Neuropathol. 2017;133:887&#x2013;906. doi: 10.1007/s00401-017-1687-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1687-9</ArticleId><ArticleId IdType="pmc">PMC5427169</ArticleId><ArticleId IdType="pubmed">28243725</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho W.Y., Chang J.C., Tyan S.H., Yen Y.C., Lim K., Tan B.S.Y., Ong J., Tucker-Kellogg G., Wong P., Koo E., et al. FUS-mediated dysregulation of Sema5a, an autism-related gene, in FUS mice with hippocampus-dependent cognitive deficits. Hum. Mol. Genet. 2019;28:3777&#x2013;3791. doi: 10.1093/hmg/ddz217.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddz217</ArticleId><ArticleId IdType="pubmed">31509188</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzman K.M., Brink L.E., Rodriguez-Bey G., Bodnar R.J., Kuang L., Xing B., Sullivan M., Park H.J., Koppes E., Zhu H., et al. Conditional depletion of Fus in oligodendrocytes leads to motor hyperactivity and increased myelin deposition associated with Akt and cholesterol activation. Glia. 2020;68:2040&#x2013;2056. doi: 10.1002/glia.23825.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23825</ArticleId><ArticleId IdType="pmc">PMC7772959</ArticleId><ArticleId IdType="pubmed">32187401</ArticleId></ArticleIdList></Reference><Reference><Citation>Stieber A., Gonatas J.O., Gonatas N.K. Aggregates of mutant protein appear progressively in dendrites, in periaxonal processes of oligodendrocytes, and in neuronal and astrocytic perikarya of mice expressing the SOD1(G93A) mutation of familial amyotrophic lateral sclerosis. J. Neurol. Sci. 2000;177:114&#x2013;123. doi: 10.1016/S0022-510X(00)00351-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(00)00351-8</ArticleId><ArticleId IdType="pubmed">10980307</ArticleId></ArticleIdList></Reference><Reference><Citation>Forsberg K., Andersen P.M., Marklund S.L., Brannstrom T. Glial nuclear aggregates of superoxide dismutase-1 are regularly present in patients with amyotrophic lateral sclerosis. Acta Neuropathol. 2011;121:623&#x2013;634. doi: 10.1007/s00401-011-0805-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-011-0805-3</ArticleId><ArticleId IdType="pmc">PMC3085063</ArticleId><ArticleId IdType="pubmed">21287393</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferraiuolo L., Meyer K., Sherwood T.W., Vick J., Likhite S., Frakes A., Miranda C.J., Braun L., Heath P.R., Pineda R., et al. Oligodendrocytes contribute to motor neuron death in ALS via SOD1-dependent mechanism. Proc. Natl. Acad. Sci. USA. 2016;113:E6496&#x2013;E6505. doi: 10.1073/pnas.1607496113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1607496113</ArticleId><ArticleId IdType="pmc">PMC5081600</ArticleId><ArticleId IdType="pubmed">27688759</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi Y., Fukuda Y., Yoshimura J., Toyoda A., Kurppa K., Moritoyo H., Belzil V.V., Dion P.A., Higasa K., Doi K., et al. ERBB4 mutations that disrupt the neuregulin-ErbB4 pathway cause amyotrophic lateral sclerosis type 19. Am. J. Hum. Genet. 2013;93:900&#x2013;905. doi: 10.1016/j.ajhg.2013.09.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2013.09.008</ArticleId><ArticleId IdType="pmc">PMC3824132</ArticleId><ArticleId IdType="pubmed">24119685</ArticleId></ArticleIdList></Reference><Reference><Citation>Sussman C.R., Vartanian T., Miller R.H. The ErbB4 neuregulin receptor mediates suppression of oligodendrocyte maturation. J. Neurosci. 2005;25:5757&#x2013;5762. doi: 10.1523/JNEUROSCI.4748-04.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4748-04.2005</ArticleId><ArticleId IdType="pmc">PMC6724872</ArticleId><ArticleId IdType="pubmed">15958742</ArticleId></ArticleIdList></Reference><Reference><Citation>Brinkmann B.G., Agarwal A., Sereda M.W., Garratt A.N., Muller T., Wende H., Stassart R.M., Nawaz S., Humml C., Velanac V., et al. Neuregulin-1/ErbB signaling serves distinct functions in myelination of the peripheral and central nervous system. Neuron. 2008;59:581&#x2013;595. doi: 10.1016/j.neuron.2008.06.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2008.06.028</ArticleId><ArticleId IdType="pmc">PMC2628490</ArticleId><ArticleId IdType="pubmed">18760695</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi Y., Uchino A., Shioya A., Sano T., Matsumoto C., Numata-Uematsu Y., Nagano S., Araki T., Murayama S., Saito Y. Altered immunoreactivity of ErbB4, a causative gene product for ALS19, in the spinal cord of patients with sporadic ALS. Neuropathology. 2019;39:268&#x2013;278. doi: 10.1111/neup.12558.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/neup.12558</ArticleId><ArticleId IdType="pmc">PMC6852233</ArticleId><ArticleId IdType="pubmed">31124187</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang S.H., Li Y., Fukaya M., Lorenzini I., Cleveland D.W., Ostrow L.W., Rothstein J.D., Bergles D.E. Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosis. Nat. Neurosci. 2013;16:571&#x2013;579. doi: 10.1038/nn.3357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3357</ArticleId><ArticleId IdType="pmc">PMC3637847</ArticleId><ArticleId IdType="pubmed">23542689</ArticleId></ArticleIdList></Reference><Reference><Citation>Magnus T., Carmen J., Deleon J., Xue H., Pardo A.C., Lepore A.C., Mattson M.P., Rao M.S., Maragakis N.J. Adult glial precursor proliferation in mutant SOD1G93A mice. Glia. 2008;56:200&#x2013;208. doi: 10.1002/glia.20604.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.20604</ArticleId><ArticleId IdType="pubmed">18023016</ArticleId></ArticleIdList></Reference><Reference><Citation>Eykens C., Nonneman A., Jensen C., Iavarone A., Van Damme P., Van Den Bosch L., Robberecht W. Conditional deletion of Id2 or Notch1 in oligodendrocyte progenitor cells does not ameliorate disease outcome in SOD1(G93A) mice. Neurobiol. Aging. 2018;68:1&#x2013;4. doi: 10.1016/j.neurobiolaging.2018.03.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2018.03.026</ArticleId><ArticleId IdType="pmc">PMC5998381</ArticleId><ArticleId IdType="pubmed">29689424</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C., Li D., Lv C., Gao Z., Qi Y., Wu H., Tian Y., Guo Y. Activation of the Notch Signaling Pathway and Cellular Localization of Notch Signaling Molecules in the Spinal Cord of SOD1-G93A ALS Model Mice. Neuroscience. 2020;432:84&#x2013;93. doi: 10.1016/j.neuroscience.2020.02.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2020.02.034</ArticleId><ArticleId IdType="pubmed">32114100</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez D., Brandan E. CTGF/CCN2 from Skeletal Muscle to Nervous System: Impact on Neurodegenerative Diseases. Mol. Neurobiol. 2019;56:5911&#x2013;5916. doi: 10.1007/s12035-019-1490-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-019-1490-9</ArticleId><ArticleId IdType="pubmed">30689195</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun S., Sun Y., Ling S.C., Ferraiuolo L., McAlonis-Downes M., Zou Y., Drenner K., Wang Y., Ditsworth D., Tokunaga S., et al. Translational profiling identifies a cascade of damage initiated in motor neurons and spreading to glia in mutant SOD1-mediated ALS. Proc. Natl. Acad. Sci. USA. 2015;112:E6993&#x2013;E7002. doi: 10.1073/pnas.1520639112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1520639112</ArticleId><ArticleId IdType="pmc">PMC4687558</ArticleId><ArticleId IdType="pubmed">26621731</ArticleId></ArticleIdList></Reference><Reference><Citation>Falcao A.M., van Bruggen D., Marques S., Meijer M., Jakel S., Agirre E., Samudyata, Floriddia E.M., Vanichkina D.P., Ffrench-Constant C., et al. Disease-specific oligodendrocyte lineage cells arise in multiple sclerosis. Nat. Med. 2018;24:1837&#x2013;1844. doi: 10.1038/s41591-018-0236-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-018-0236-y</ArticleId><ArticleId IdType="pmc">PMC6544508</ArticleId><ArticleId IdType="pubmed">30420755</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirby L., Jin J., Cardona J.G., Smith M.D., Martin K.A., Wang J., Strasburger H., Herbst L., Alexis M., Karnell J., et al. Oligodendrocyte precursor cells present antigen and are cytotoxic targets in inflammatory demyelination. Nat. Commun. 2019;10:3887. doi: 10.1038/s41467-019-11638-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-11638-3</ArticleId><ArticleId IdType="pmc">PMC6715717</ArticleId><ArticleId IdType="pubmed">31467299</ArticleId></ArticleIdList></Reference><Reference><Citation>Livesey M.R., Magnani D., Cleary E.M., Vasistha N.A., James O.T., Selvaraj B.T., Burr K., Story D., Shaw C.E., Kind P.C., et al. Maturation and electrophysiological properties of human pluripotent stem cell-derived oligodendrocytes. Stem. Cells. 2016;34:1040&#x2013;1053. doi: 10.1002/stem.2273.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/stem.2273</ArticleId><ArticleId IdType="pmc">PMC4840312</ArticleId><ArticleId IdType="pubmed">26763608</ArticleId></ArticleIdList></Reference><Reference><Citation>Langseth A.J., Kim J., Ugolino J.E., Shah Y., Hwang H.Y., Wang J., Bergles D.E., Brown S.P. Cell-type specific differences in promoter activity of the ALS-linked C9orf72 mouse ortholog. Sci. Rep. 2017;7:5685. doi: 10.1038/s41598-017-05864-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-05864-2</ArticleId><ArticleId IdType="pmc">PMC5515847</ArticleId><ArticleId IdType="pubmed">28720882</ArticleId></ArticleIdList></Reference><Reference><Citation>Andres-Benito P., Moreno J., Aso E., Povedano M., Ferrer I. Amyotrophic lateral sclerosis, gene deregulation in the anterior horn of the spinal cord and frontal cortex area 8: Implications in frontotemporal lobar degeneration. Aging. 2017;9:823&#x2013;851. doi: 10.18632/aging.101195.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.101195</ArticleId><ArticleId IdType="pmc">PMC5391234</ArticleId><ArticleId IdType="pubmed">28283675</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y.J., Tang Y.F., Xiao Z.C., Bao Z.M., He B.P. NG2 cells response to axonal alteration in the spinal cord white matter in mice with genetic disruption of neurofilament light subunit expression. Mol. Neurodegener. 2008;3:18. doi: 10.1186/1750-1326-3-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-3-18</ArticleId><ArticleId IdType="pmc">PMC2584033</ArticleId><ArticleId IdType="pubmed">18957081</ArticleId></ArticleIdList></Reference><Reference><Citation>Bogaert E., d&#x2019;Ydewalle C., Van Den Bosch L. Amyotrophic lateral sclerosis and excitotoxicity: From pathological mechanism to therapeutic target. CNS Neurol. Disord. Drug Targets. 2010;9:297&#x2013;304. doi: 10.2174/187152710791292576.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/187152710791292576</ArticleId><ArticleId IdType="pubmed">20406181</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito Y., Yamada M., Tanaka H., Aida K., Tsuruma K., Shimazawa M., Hozumi I., Inuzuka T., Takahashi H., Hara H. Involvement of CHOP, an ER-stress apoptotic mediator, in both human sporadic ALS and ALS model mice. Neurobiol. Dis. 2009;36:470&#x2013;476. doi: 10.1016/j.nbd.2009.08.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2009.08.013</ArticleId><ArticleId IdType="pubmed">19733664</ArticleId></ArticleIdList></Reference><Reference><Citation>Montibeller L., Tan L.Y., Kim J.K., Paul P., de Belleroche J. Tissue-selective regulation of protein homeostasis and unfolded protein response signaling in sporadic ALS. J. Cell Mol. Med. 2020;24:6055&#x2013;6069. doi: 10.1111/jcmm.15170.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.15170</ArticleId><ArticleId IdType="pmc">PMC7294118</ArticleId><ArticleId IdType="pubmed">32324341</ArticleId></ArticleIdList></Reference><Reference><Citation>Bond L., Bernhardt K., Madria P., Sorrentino K., Scelsi H., Mitchell C.S. A Metadata Analysis of Oxidative Stress Etiology in Preclinical Amyotrophic Lateral Sclerosis: Benefits of Antioxidant Therapy. Front. Neurosci. 2018;12:10. doi: 10.3389/fnins.2018.00010.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2018.00010</ArticleId><ArticleId IdType="pmc">PMC5787557</ArticleId><ArticleId IdType="pubmed">29416499</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang Y., Kong Q., Shan X., Tian G., Ilieva H., Cleveland D.W., Rothstein J.D., Borchelt D.R., Wong P.C., Lin C.L. Messenger RNA oxidation occurs early in disease pathogenesis and promotes motor neuron degeneration in ALS. PLoS ONE. 2008;3:e2849. doi: 10.1371/journal.pone.0002849.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0002849</ArticleId><ArticleId IdType="pmc">PMC2481395</ArticleId><ArticleId IdType="pubmed">18682740</ArticleId></ArticleIdList></Reference><Reference><Citation>Highley J.R., Kirby J., Jansweijer J.A., Webb P.S., Hewamadduma C.A., Heath P.R., Higginbottom A., Raman R., Ferraiuolo L., Cooper-Knock J., et al. Loss of nuclear TDP-43 in amyotrophic lateral sclerosis (ALS) causes altered expression of splicing machinery and widespread dysregulation of RNA splicing in motor neurones. Neuropathol. Appl. Neurobiol. 2014;40:670&#x2013;685. doi: 10.1111/nan.12148.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12148</ArticleId><ArticleId IdType="pubmed">24750229</ArticleId></ArticleIdList></Reference><Reference><Citation>Deshaies J.E., Shkreta L., Moszczynski A.J., Sidibe H., Semmler S., Fouillen A., Bennett E.R., Bekenstein U., Destroismaisons L., Toutant J., et al. TDP-43 regulates the alternative splicing of hnRNP A1 to yield an aggregation-prone variant in amyotrophic lateral sclerosis. Brain. 2018;141:1320&#x2013;1333. doi: 10.1093/brain/awy062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awy062</ArticleId><ArticleId IdType="pmc">PMC5917749</ArticleId><ArticleId IdType="pubmed">29562314</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper-Knock J., Walsh M.J., Higginbottom A., Robin Highley J., Dickman M.J., Edbauer D., Ince P.G., Wharton S.B., Wilson S.A., Kirby J., et al. Sequestration of multiple RNA recognition motif-containing proteins by C9orf72 repeat expansions. Brain. 2014;137:2040&#x2013;2051. doi: 10.1093/brain/awu120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awu120</ArticleId><ArticleId IdType="pmc">PMC4065024</ArticleId><ArticleId IdType="pubmed">24866055</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandler M.D., Ku L., Feng Y. A cytoplasmic quaking I isoform regulates the hnRNP F/H-dependent alternative splicing pathway in myelinating glia. Nucleic Acids Res. 2014;42:7319&#x2013;7329. doi: 10.1093/nar/gku353.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gku353</ArticleId><ArticleId IdType="pmc">PMC4066780</ArticleId><ArticleId IdType="pubmed">24792162</ArticleId></ArticleIdList></Reference><Reference><Citation>Traiffort E., Kassoussi A., Zahaf A., Laouarem Y. Astrocytes and microglia as major players of myelin production in normal and pathological conditions. Front. Cell. Neurosci. 2020;14:79. doi: 10.3389/fncel.2020.00079.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2020.00079</ArticleId><ArticleId IdType="pmc">PMC7155218</ArticleId><ArticleId IdType="pubmed">32317939</ArticleId></ArticleIdList></Reference><Reference><Citation>Clemente D., Ortega M.C., Melero-Jerez C., de Castro F. The effect of glia-glia interactions on oligodendrocyte precursor cell biology during development and in demyelinating diseases. Front. Cell. Neurosci. 2013;7:268. doi: 10.3389/fncel.2013.00268.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2013.00268</ArticleId><ArticleId IdType="pmc">PMC3868919</ArticleId><ArticleId IdType="pubmed">24391545</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., Zhang L., Chu Y., Namaka M., Deng B., Kong J., Bi X. Astrocytes in Oligodendrocyte Lineage Development and White Matter Pathology. Front. Cell. Neurosci. 2016;10:119. doi: 10.3389/fncel.2016.00119.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2016.00119</ArticleId><ArticleId IdType="pmc">PMC4861901</ArticleId><ArticleId IdType="pubmed">27242432</ArticleId></ArticleIdList></Reference><Reference><Citation>Almad A.A., Doreswamy A., Gross S.K., Richard J.P., Huo Y., Haughey N., Maragakis N.J. Connexin 43 in astrocytes contributes to motor neuron toxicity in amyotrophic lateral sclerosis. Glia. 2016;64:1154&#x2013;1169. doi: 10.1002/glia.22989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.22989</ArticleId><ArticleId IdType="pmc">PMC5635605</ArticleId><ArticleId IdType="pubmed">27083773</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui Y., Masaki K., Yamasaki R., Imamura S., Suzuki S.O., Hayashi S., Sato S., Nagara Y., Kawamura M.F., Kira J. Extensive dysregulations of oligodendrocytic and astrocytic connexins are associated with disease progression in an amyotrophic lateral sclerosis mouse model. J. Neuroinflammation. 2014;11:42. doi: 10.1186/1742-2094-11-42.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-11-42</ArticleId><ArticleId IdType="pmc">PMC4016493</ArticleId><ArticleId IdType="pubmed">24597481</ArticleId></ArticleIdList></Reference><Reference><Citation>Menichella D.M., Goodenough D.A., Sirkowski E., Scherer S.S., Paul D.L. Connexins are critical for normal myelination in the CNS. J. Neurosci. 2003;23:5963&#x2013;5973. doi: 10.1523/JNEUROSCI.23-13-05963.2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.23-13-05963.2003</ArticleId><ArticleId IdType="pmc">PMC6741267</ArticleId><ArticleId IdType="pubmed">12843301</ArticleId></ArticleIdList></Reference><Reference><Citation>Lloyd A.F., Davies C.L., Miron V.E. Microglia: Origins, homeostasis, and roles in myelin repair. Curr. Opin. Neurobiol. 2017;47:113&#x2013;120. doi: 10.1016/j.conb.2017.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.conb.2017.10.001</ArticleId><ArticleId IdType="pubmed">29073528</ArticleId></ArticleIdList></Reference><Reference><Citation>Maruyama H., Morino H., Ito H., Izumi Y., Kato H., Watanabe Y., Kinoshita Y., Kamada M., Nodera H., Suzuki H., et al. Mutations of optineurin in amyotrophic lateral sclerosis. Nature. 2010;465:223&#x2013;226. doi: 10.1038/nature08971.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature08971</ArticleId><ArticleId IdType="pubmed">20428114</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorente Pons A., Higginbottom A., Cooper-Knock J., Alrafiah A., Alofi E., Kirby J., Shaw P.J., Wood J.D., Highley J.R. Oligodendrocyte pathology exceeds axonal pathology in white matter in human amyotrophic lateral sclerosis. J. Pathol. 2020;251:262&#x2013;271. doi: 10.1002/path.5455.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.5455</ArticleId><ArticleId IdType="pubmed">32391572</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S., Chung A.Y., Na J.E., Lee S.J., Jeong S.H., Kim E., Sun W., Rhyu I.J., Park H.C. Myelin degeneration induced by mutant superoxide dismutase 1 accumulation promotes amyotrophic lateral sclerosis. Glia. 2019;67:1910&#x2013;1921. doi: 10.1002/glia.23669.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23669</ArticleId><ArticleId IdType="pubmed">31290185</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaarsma D., Teuling E., Haasdijk E.D., De Zeeuw C.I., Hoogenraad C.C. Neuron-specific expression of mutant superoxide dismutase is sufficient to induce amyotrophic lateral sclerosis in transgenic mice. J. Neurosci. 2008;28:2075&#x2013;2088. doi: 10.1523/JNEUROSCI.5258-07.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.5258-07.2008</ArticleId><ArticleId IdType="pmc">PMC6671838</ArticleId><ArticleId IdType="pubmed">18305242</ArticleId></ArticleIdList></Reference><Reference><Citation>Fatima M., Tan R., Halliday G.M., Kril J.J. Spread of pathology in amyotrophic lateral sclerosis: Assessment of phosphorylated TDP-43 along axonal pathways. Acta Neuropathol. Commun. 2015;3:47. doi: 10.1186/s40478-015-0226-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-015-0226-y</ArticleId><ArticleId IdType="pmc">PMC4517552</ArticleId><ArticleId IdType="pubmed">26216351</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas E.V., Fenton W.A., McGrath J., Horwich A.L. Transfer of pathogenic and nonpathogenic cytosolic proteins between spinal cord motor neurons in vivo in chimeric mice. Proc. Natl. Acad. Sci. USA. 2017;114:E3139&#x2013;E3148. doi: 10.1073/pnas.1701465114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1701465114</ArticleId><ArticleId IdType="pmc">PMC5393223</ArticleId><ArticleId IdType="pubmed">28348221</ArticleId></ArticleIdList></Reference><Reference><Citation>Oluich L.J., Stratton J.A., Xing Y.L., Ng S.W., Cate H.S., Sah P., Windels F., Kilpatrick T.J., Merson T.D. Targeted ablation of oligodendrocytes induces axonal pathology independent of overt demyelination. J. Neurosci. 2012;32:8317&#x2013;8330. doi: 10.1523/JNEUROSCI.1053-12.2012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1053-12.2012</ArticleId><ArticleId IdType="pmc">PMC6703635</ArticleId><ArticleId IdType="pubmed">22699912</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith C.M., Cooksey E., Duncan I.D. Myelin loss does not lead to axonal degeneration in a long-lived model of chronic demyelination. J. Neurosci. 2013;33:2718&#x2013;2727. doi: 10.1523/JNEUROSCI.4627-12.2013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4627-12.2013</ArticleId><ArticleId IdType="pmc">PMC4128634</ArticleId><ArticleId IdType="pubmed">23392698</ArticleId></ArticleIdList></Reference><Reference><Citation>Barros L.F. Metabolic signaling by lactate in the brain. Trends Neurosci. 2013;36:396&#x2013;404. doi: 10.1016/j.tins.2013.04.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2013.04.002</ArticleId><ArticleId IdType="pubmed">23639382</ArticleId></ArticleIdList></Reference><Reference><Citation>Satoh J., Asahina N., Kitano S., Kino Y. A Comprehensive Profile of ChIP-Seq-Based Olig2 Target Genes in Motor Neuron Progenitor Cells Suggests the Possible Involvement of Olig2 in the Pathogenesis of Amyotrophic Lateral Sclerosis. J. Cent. Nerv. Syst. Dis. 2015;7:1&#x2013;14. doi: 10.4137/JCNSD.S23210.</Citation><ArticleIdList><ArticleId IdType="doi">10.4137/JCNSD.S23210</ArticleId><ArticleId IdType="pmc">PMC4437538</ArticleId><ArticleId IdType="pubmed">26023283</ArticleId></ArticleIdList></Reference><Reference><Citation>Starikov L., Kottmann A.H. Diminished Ventral Oligodendrocyte Precursor Generation Results in the Subsequent Over-production of Dorsal Oligodendrocyte Precursors of Aberrant Morphology and Function. Neuroscience. 2020;450:15&#x2013;28. doi: 10.1016/j.neuroscience.2020.05.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2020.05.027</ArticleId><ArticleId IdType="pubmed">32450295</ArticleId></ArticleIdList></Reference><Reference><Citation>Bensimon G., Lacomblez L., Meininger V. A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. N. Engl. J. Med. 1994;330:585&#x2013;591. doi: 10.1056/NEJM199403033300901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199403033300901</ArticleId><ArticleId IdType="pubmed">8302340</ArticleId></ArticleIdList></Reference><Reference><Citation>Filipi T., Hermanova Z., Tureckova J., Vanatko O., Anderova A.M. Glial Cells-The Strategic Targets in Amyotrophic Lateral Sclerosis Treatment. J. Clin. Med. 2020;9:261. doi: 10.3390/jcm9010261.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9010261</ArticleId><ArticleId IdType="pmc">PMC7020059</ArticleId><ArticleId IdType="pubmed">31963681</ArticleId></ArticleIdList></Reference><Reference><Citation>Trias E., Ibarburu S., Barreto-Nunez R., Varela V., Moura I.C., Dubreuil P., Hermine O., Beckman J.S., Barbeito L. Evidence for mast cells contributing to neuromuscular pathology in an inherited model of ALS. JCI Insight. 2017;2 doi: 10.1172/jci.insight.95934.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.95934</ArticleId><ArticleId IdType="pmc">PMC5846907</ArticleId><ArticleId IdType="pubmed">29046475</ArticleId></ArticleIdList></Reference><Reference><Citation>Mora J.S., Genge A., Chio A., Estol C.J., Chaverri D., Hernandez M., Marin S., Mascias J., Rodriguez G.E., Povedano M., et al. Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: A randomized clinical trial. Amyotroph. Lateral Scler. Front. Degener. 2020;21:5&#x2013;14. doi: 10.1080/21678421.2019.1632346.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2019.1632346</ArticleId><ArticleId IdType="pubmed">31280619</ArticleId></ArticleIdList></Reference><Reference><Citation>Cappella M., Ciotti C., Cohen-Tannoudji M., Biferi M.G. Gene Therapy for ALS-A Perspective. Int. J. Mol. Sci. 2019;20:4388. doi: 10.3390/ijms20184388.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20184388</ArticleId><ArticleId IdType="pmc">PMC6771059</ArticleId><ArticleId IdType="pubmed">31500113</ArticleId></ArticleIdList></Reference><Reference><Citation>Karagiannis P., Inoue H. ALS, a cellular whodunit on motor neuron degeneration. Mol. Cell. Neurosci. 2020;107:103524. doi: 10.1016/j.mcn.2020.103524.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2020.103524</ArticleId><ArticleId IdType="pubmed">32629110</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller T.M., Pestronk A., David W., Rothstein J., Simpson E., Appel S.H., Andres P.L., Mahoney K., Allred P., Alexander K., et al. An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: A phase 1, randomised, first-in-man study. Lancet Neurol. 2013;12:435&#x2013;442. doi: 10.1016/S1474-4422(13)70061-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(13)70061-9</ArticleId><ArticleId IdType="pmc">PMC3712285</ArticleId><ArticleId IdType="pubmed">23541756</ArticleId></ArticleIdList></Reference><Reference><Citation>Donnelly C.J., Zhang P.W., Pham J.T., Haeusler A.R., Mistry N.A., Vidensky S., Daley E.L., Poth E.M., Hoover B., Fines D.M., et al. RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention. Neuron. 2013;80:415&#x2013;428. doi: 10.1016/j.neuron.2013.10.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.10.015</ArticleId><ArticleId IdType="pmc">PMC4098943</ArticleId><ArticleId IdType="pubmed">24139042</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang J., Cleveland D.W. Bidirectional Transcriptional Inhibition as Therapy for ALS/FTD Caused by Repeat Expansion in C9orf72. Neuron. 2016;92:1160&#x2013;1163. doi: 10.1016/j.neuron.2016.12.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.12.008</ArticleId><ArticleId IdType="pubmed">28009271</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Dodart J.C., Tran H., Berkovitch S., Braun M., Byrne M., Durbin A.F., Hu X.S., Iwamoto N., Jang H.G., et al. Variant-selective stereopure oligonucleotides protect against pathologies associated with C9orf72-repeat expansion in preclinical models. Nat. Commun. 2021;12:847. doi: 10.1038/s41467-021-21112-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-21112-8</ArticleId><ArticleId IdType="pmc">PMC7870851</ArticleId><ArticleId IdType="pubmed">33558503</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker L.A., Huang B., Bieri G., Ma R., Knowles D.A., Jafar-Nejad P., Messing J., Kim H.J., Soriano A., Auburger G., et al. Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice. Nature. 2017;544:367&#x2013;371. doi: 10.1038/nature22038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature22038</ArticleId><ArticleId IdType="pmc">PMC5642042</ArticleId><ArticleId IdType="pubmed">28405022</ArticleId></ArticleIdList></Reference><Reference><Citation>Mejzini R., Flynn L.L., Pitout I.L., Fletcher S., Wilton S.D., Akkari P.A. ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now? Front. Neurosci. 2019;13:1310. doi: 10.3389/fnins.2019.01310.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.01310</ArticleId><ArticleId IdType="pmc">PMC6909825</ArticleId><ArticleId IdType="pubmed">31866818</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller T., Cudkowicz M., Shaw P.J., Andersen P.M., Atassi N., Bucelli R.C., Genge A., Glass J., Ladha S., Ludolph A.L., et al. Phase 1-2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS. N. Engl. J. Med. 2020;383:109&#x2013;119. doi: 10.1056/NEJMoa2003715.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2003715</ArticleId><ArticleId IdType="pubmed">32640130</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen P.C., Hsieh Y.C., Huang C.C., Hu C.J. Tamoxifen for amyotrophic lateral sclerosis: A randomized double-blind clinical trial. Medicine. 2020;99:e20423. doi: 10.1097/MD.0000000000020423.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000020423</ArticleId><ArticleId IdType="pubmed">32481440</ArticleId></ArticleIdList></Reference><Reference><Citation>Apolloni S., Fabbrizio P., Amadio S., Volonte C. Actions of the antihistaminergic clemastine on presymptomatic SOD1-G93A mice ameliorate ALS disease progression. J. Neuroinflamm. 2016;13:191. doi: 10.1186/s12974-016-0658-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-016-0658-8</ArticleId><ArticleId IdType="pmc">PMC4994328</ArticleId><ArticleId IdType="pubmed">27549088</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonfanti E., Bonifacino T., Raffaele S., Milanese M., Morgante E., Bonanno G., Abbracchio M.P., Fumagalli M. Abnormal Upregulation of GPR17 Receptor Contributes to Oligodendrocyte Dysfunction in SOD1 G93A Mice. Int. J. Mol. Sci. 2020;21:2395. doi: 10.3390/ijms21072395.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21072395</ArticleId><ArticleId IdType="pmc">PMC7177925</ArticleId><ArticleId IdType="pubmed">32244295</ArticleId></ArticleIdList></Reference><Reference><Citation>Riancho J., Ruiz-Soto M., Berciano M.T., Berciano J., Lafarga M. Neuroprotective Effect of Bexarotene in the SOD1(G93A) Mouse Model of Amyotrophic Lateral Sclerosis. Front. Cell. Neurosci. 2015;9:250. doi: 10.3389/fncel.2015.00250.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2015.00250</ArticleId><ArticleId IdType="pmc">PMC4486838</ArticleId><ArticleId IdType="pubmed">26190974</ArticleId></ArticleIdList></Reference><Reference><Citation>Juntas-Morales R., Pageot N., Bendarraz A., Alphandery S., Sedel F., Seigle S., Camu W. High-dose pharmaceutical grade biotin (MD1003) in amyotrophic lateral sclerosis: A pilot study. EClinicalMedicine. 2020;19:100254. doi: 10.1016/j.eclinm.2019.100254.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2019.100254</ArticleId><ArticleId IdType="pmc">PMC7046518</ArticleId><ArticleId IdType="pubmed">32140672</ArticleId></ArticleIdList></Reference><Reference><Citation>Paganoni S., Alshikho M.J., Luppino S., Chan J., Pothier L., Schoenfeld D., Andres P.L., Babu S., Zurcher N.R., Loggia M.L., et al. A pilot trial of RNS60 in amyotrophic lateral sclerosis. Muscle Nerve. 2019;59:303&#x2013;308. doi: 10.1002/mus.26385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.26385</ArticleId><ArticleId IdType="pmc">PMC6379136</ArticleId><ArticleId IdType="pubmed">30458059</ArticleId></ArticleIdList></Reference><Reference><Citation>Vallarola A., Sironi F., Tortarolo M., Gatto N., De Gioia R., Pasetto L., De Paola M., Mariani A., Ghosh S., Watson R., et al. RNS60 exerts therapeutic effects in the SOD1 ALS mouse model through protective glia and peripheral nerve rescue. J. Neuroinflamm. 2018;15:65. doi: 10.1186/s12974-018-1101-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-018-1101-0</ArticleId><ArticleId IdType="pmc">PMC5833072</ArticleId><ArticleId IdType="pubmed">29495962</ArticleId></ArticleIdList></Reference><Reference><Citation>Espejo-Porras F., Garcia-Toscano L., Rodriguez-Cueto C., Santos-Garcia I., de Lago E., Fernandez-Ruiz J. Targeting glial cannabinoid CB2 receptors to delay the progression of the pathological phenotype in TDP-43 (A315T) transgenic mice, a model of amyotrophic lateral sclerosis. Br. J. Pharmacol. 2019;176:1585&#x2013;1600. doi: 10.1111/bph.14216.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.14216</ArticleId><ArticleId IdType="pmc">PMC6487601</ArticleId><ArticleId IdType="pubmed">29574689</ArticleId></ArticleIdList></Reference><Reference><Citation>Gugliandolo A., Bramanti P., Mazzon E. Mesenchymal Stem Cells: A Potential Therapeutic Approach for Amyotrophic Lateral Sclerosis? Stem Cells Int. 2019;2019:3675627. doi: 10.1155/2019/3675627.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/3675627</ArticleId><ArticleId IdType="pmc">PMC6431432</ArticleId><ArticleId IdType="pubmed">30956667</ArticleId></ArticleIdList></Reference><Reference><Citation>Myszczynska M., Ferraiuolo L. New In Vitro Models to Study Amyotrophic Lateral Sclerosis. Brain Pathol. 2016;26:258&#x2013;265. doi: 10.1111/bpa.12353.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12353</ArticleId><ArticleId IdType="pmc">PMC8029155</ArticleId><ArticleId IdType="pubmed">26780562</ArticleId></ArticleIdList></Reference><Reference><Citation>Philips T., Rothstein J.D. Oligodendroglia: Metabolic supporters of neurons. J. Clin. Investig. 2017;127:3271&#x2013;3280. doi: 10.1172/JCI90610.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI90610</ArticleId><ArticleId IdType="pmc">PMC5669561</ArticleId><ArticleId IdType="pubmed">28862639</ArticleId></ArticleIdList></Reference><Reference><Citation>Kunis G., Baruch K., Miller O., Schwartz M. Immunization with a Myelin-Derived Antigen Activates the Brain&#x2019;s Choroid Plexus for Recruitment of Immunoregulatory Cells to the CNS and Attenuates Disease Progression in a Mouse Model of ALS. J. Neurosci. 2015;35:6381&#x2013;6393. doi: 10.1523/JNEUROSCI.3644-14.2015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3644-14.2015</ArticleId><ArticleId IdType="pmc">PMC6605216</ArticleId><ArticleId IdType="pubmed">25904790</ArticleId></ArticleIdList></Reference><Reference><Citation>Lubetzki C., Zalc B., Williams A., Stadelmann C., Stankoff B. Remyelination in multiple sclerosis: From basic science to clinical translation. Lancet Neurol. 2020;19:678&#x2013;688. doi: 10.1016/S1474-4422(20)30140-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30140-X</ArticleId><ArticleId IdType="pubmed">32702337</ArticleId></ArticleIdList></Reference><Reference><Citation>Green A.J., Gelfand J.M., Cree B.A., Bevan C., Boscardin W.J., Mei F., Inman J., Arnow S., Devereux M., Abounasr A., et al. Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): A randomised, controlled, double-blind, crossover trial. Lancet. 2017;390:2481&#x2013;2489. doi: 10.1016/S0140-6736(17)32346-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)32346-2</ArticleId><ArticleId IdType="pubmed">29029896</ArticleId></ArticleIdList></Reference><Reference><Citation>Bechler M.E., Byrne L., Ffrench-Constant C. CNS Myelin Sheath Lengths Are an Intrinsic Property of Oligodendrocytes. Curr. Biol. 2015;25:2411&#x2013;2416. doi: 10.1016/j.cub.2015.07.056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2015.07.056</ArticleId><ArticleId IdType="pmc">PMC4580335</ArticleId><ArticleId IdType="pubmed">26320951</ArticleId></ArticleIdList></Reference><Reference><Citation>Lloyd A.F., Miron V.E. The pro-remyelination properties of microglia in the central nervous system. Nat. Rev. Neurol. 2019 doi: 10.1038/s41582-019-0184-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-019-0184-2</ArticleId><ArticleId IdType="pubmed">31256193</ArticleId></ArticleIdList></Reference><Reference><Citation>Laouarem Y., Kassoussi A., Zahaf A., Hutteau-Hamel T., Mellouk A., Bobe P., Mattern C., Schumacher M., Traiffort E. Functional cooperation of the hedgehog and androgen signaling pathways during developmental and repairing myelination. Glia. 2021 doi: 10.1002/glia.23967.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23967</ArticleId><ArticleId IdType="pubmed">33484204</ArticleId></ArticleIdList></Reference><Reference><Citation>Mei F., Fancy S.P., Shen Y.A., Niu J., Zhao C., Presley B., Miao E., Lee S., Mayoral S.R., Redmond S.A., et al. Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosis. Nat. Med. 2014;20:954&#x2013;960. doi: 10.1038/nm.3618.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.3618</ArticleId><ArticleId IdType="pmc">PMC4830134</ArticleId><ArticleId IdType="pubmed">24997607</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Leon J.A., Kumar M., Boon R., Chau D., One J., Wolfs E., Eggermont K., Berckmans P., Gunhanlar N., de Vrij F., et al. SOX10 Single Transcription Factor-Based Fast and Efficient Generation of Oligodendrocytes from Human Pluripotent Stem Cells. Stem. Cell Rep. 2018;10:655&#x2013;672. doi: 10.1016/j.stemcr.2017.12.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2017.12.014</ArticleId><ArticleId IdType="pmc">PMC5830935</ArticleId><ArticleId IdType="pubmed">29337119</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>